HOSP || Infectious Diseases

Inpatient cirrhosis mortality has dropped, except when patients had sepsis

Posted on: 01/05/2015 - 05:01

Hospital mortality among patients with cirrhosis fell by 41% in the United States between 2002 and 2010, far outpacing improvements in survival among ... More »

Field of Interest: Gastroentero...

Type: News Item

Manufacturer releases new reprocessing instructions for TJF-Q180V duodenoscope

Posted on: 27/03/2015 - 20:22

Olympus, the manufacturer of the TJF-Q180V duodenoscope, has issued new, validated instructions for reprocessing this particular model, as part of the... More »

Field of Interest: Gastroentero...

Type: News Item

Novel HCV therapies found cost effective, with caveats

Posted on: 16/03/2015 - 21:00

Two different statistical models found that novel therapies for chronic HCV infection, particularly the combination of sofosbuvir and ledipasvir, are ... More »

Field of Interest: Gastroentero...

Type: News Item

C. difficile recurrences steady, but drive costly readmissions

Posted on: 19/10/2014 - 20:24

PHILADELPHIA – Every recurrence of Clostridium difficile was associated with a hospital admission in 1 in 4 cases and a complication in 1 in 15 cases, according to a retrospective Canadian...

Field of Interest: Gastroentero...

Type: News Item

Microbiome-based pill holds promise for chronic C. difficile

Posted on: 11/09/2014 - 18:15

WASHINGTON – A rationally designed microbiome-based pill successfully eradicated recurrent Clostridium difficile infection in 29 of 30 patients in an <link...

Field of Interest: Gastroentero...

Type: News Item

FDA approves dalbavancin for acute bacterial skin infections

Posted on: 23/05/2014 - 22:20

Dalbavancin is the first drug with a Qualified Infectious Disease Product designation to be approved by the Food and Drug Administration. On May 23, the agency approved dalbavancin (<link...

Field of Interest: Dermatology

Type: News Item

PEARL-II: Oral ‘3D’ regimen effective in hepatitis C with prior treatment failure

Posted on: 13/05/2014 - 22:20

CHICAGO – The investigational "3D" combination of oral antiviral drugs achieved a cure rate that was nothing short of sensational in the phase III PEARL-II trial involving noncirrhotic...

Field of Interest: Infectious diseases

Type: News Item

PEARL-II: Oral ‘3D’ regimen effective in hepatitis C with prior treatment failure

Posted on: 13/05/2014 - 22:20

CHICAGO – The investigational "3D" combination of oral antiviral drugs achieved a cure rate that was nothing short of sensational in the phase III PEARL-II trial involving noncirrhotic...

Field of Interest: Gastroentero...

Type: News Item

What puts C. diff patients at greater readmission risk?

Posted on: 09/05/2014 - 21:35

CHICAGO – More and more elderly people are getting infected with Clostridium difficile, and many get readmitted to the hospital after initial treatment for this potentially deadly diarrheal...

Field of Interest: Gastroentero...

Type: News Item

What puts C. diff patients at greater readmission risk?

Posted on: 09/05/2014 - 21:35

CHICAGO – More and more elderly people are getting infected with Clostridium difficile, and many get readmitted to the hospital after initial treatment for this potentially deadly diarrheal...

Field of Interest: Geriatrics

Type: News Item

Inpatient cirrhosis mortality has dropped, except when patients had sepsis

Manufacturer releases new reprocessing instructions for TJF-Q180V duodenoscope

Novel HCV therapies found cost effective, with caveats

C. difficile recurrences steady, but drive costly readmissions

Microbiome-based pill holds promise for chronic C. difficile

FDA approves dalbavancin for acute bacterial skin infections

PEARL-II: Oral ‘3D’ regimen effective in hepatitis C with prior treatment failure

PEARL-II: Oral ‘3D’ regimen effective in hepatitis C with prior treatment failure

What puts C. diff patients at greater readmission risk?

What puts C. diff patients at greater readmission risk?

Newsletters

Latest Newsletters

You are here

HOSP || Infectious Diseases

Newsletters

Latest Newsletters